Regulators In Japan Cut Away At New Drug Review Time
This article was originally published in The Pink Sheet Daily
Executive Summary
The Japanese government is trying to eliminate the drug lag by the year 2011 under a five-year strategic plan covering the creation of innovative pharmaceuticals and medical devices.
You may also be interested in...
Tokyo Aims To Speed Up Drug Approvals, Catch Up With U.S., Says Japanese Health Ministry Official
TOKYO - Japan is in the process of aligning itself with global pharmaceutical standards, according to Shuichi Kishida, councilor for pharmaceutical safety at the Ministry of Health, Labor and Welfare
Cancer-Genomics Firm Quanticel Debuts With Close Ties To Celgene, And An Exit In Mind
Celgene will get exclusive use of Quanticel's single-cell genomic analysis to tweak its clinical pipeline, and it also has exclusive options to acquire the venture-backed start-up.
One Trial Plus Supportive Evidence Is Enough For Hospital-, Ventilator-Acquired Pneumonia Indication, Panel Says
Anti-Infective Drugs Advisory Committee members viewed one-trial as practical means of gaining efficacy data.